Salicylate pharmacokinetics in patients with rheumatoid arthritis
about
Drug structure-transport relationshipsSynovial distribution of "systemically" administered acetylsalicylic acid in the isolated perfused equine distal limbIbuprofen inhibits colitis-induced overexpression of tumor-related Rac1bModel representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.
P2860
Salicylate pharmacokinetics in patients with rheumatoid arthritis
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@ast
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@en
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@nl
type
label
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@ast
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@en
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@nl
prefLabel
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@ast
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@en
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@nl
P2093
P2860
P1476
Salicylate pharmacokinetics in patients with rheumatoid arthritis
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1989.TB03526.X
P407
P577
1989-10-01T00:00:00Z